(EPD, CRWE, WFC, AFFY) BestOTC.com Stock Market Report
4/14/2012 7:34:56 PM
Enterprise Products Partners L.P. (NYSE:EPD) will announce its first quarter earnings on Wednesday, May 2, 2012, before the New York Stock Exchange opens for trading.
Following the announcement, the company will host a conference call at 9 a.m. CT with analysts and investors to discuss first quarter earnings.
Traditional media is two-dimensional, but online advertising is multi-dimensional, which can combine word, image and sound to convey multi-sensory information, enabling customers to experience lifelike goods or service.
Crown Equity Holdings Inc. (CRWE.OB) offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them.
CRWEs advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.
CRWEs division CRWE AD-Services (www.crwe-adservices.com), is a full service multimedia advertising company specializing in internet marketing. It provides modern and unique advertising campaigns, dedicated to offering the most cost effective advertising solutions.
Today audience spends less and less time on watching of TV and reading of press, but more and more on Internet surfing. So online advertising is the most effective way to deliver information on products and services to prospective customers.
More about CRWE at
Wells Fargo & Company (NYSE:WFC) reported record net income of $4.2 billion, or $0.75 per diluted common share, for first quarter 2012, compared with $3.8 billion, or $0.67 per share, for first quarter 2011, and $4.1 billion, or $0.73 per share, for fourth quarter 2011.
Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceuticals U.S.A. (TPUSA) reported that the Centers for Medicare and Medicaid Services (CMS) has granted a unique product reimbursement code, or Q-code, for OMONTYS® (peginesatide) Injection.
The OMONTYS-specific billing code, Q2047, will help streamline the billing process for dialysis organizations using OMONTYS. This new Q-code will become effective on July 1, 2012. OMONTYS is the only once-monthly erythropoiesis-stimulating agent (ESA) for anemia available to the dialysis patient population in the United States.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (